According to the requirements of relevant laws and regulations, the environmental protection acceptance report for the completion of the Shandong Loncom Pharmaceutical Co., Ltd.-an annual output of 15,000 kg of rosuvastatin calcium and new drug research and development base project (second-phase comprehensive preparation) is now published in full.

Mailing address: Department of Safety and Environmental Protection, Shandong Langcom Pharmaceutical Co., Ltd., Qihe Economic Development Zone, Shandong Province

Telephone: 0534-5025636

Email: langnuo5636@163.com